Immunovant Inc (IMVT) — Defensive Interval Ratio
Immunovant Inc (IMVT) has a Defensive Interval Ratio of 2 days as of June 2026. Defensive assets of $697.00K (cash $-, short-term investments $-, receivables $697.00K) cover 2 days of daily cash needs of $320.83K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Immunovant Inc Defensive Interval Ratio (2019–2026)
This chart shows how Immunovant Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2019 to 2026. As of June 2026, the ratio stands at 2 days, meaning defensive assets of $697.00K can fund 2 days of operations without new revenue. For the complete balance sheet picture, see IMVT asset base.
Annual Defensive Interval Ratio for Immunovant Inc (2019–2026)
The table below presents the year-by-year Defensive Interval Ratio for Immunovant Inc from 2019 to 2026, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See IMVT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2026 | 14 days | $3.95 Million | $286.09K/day | $- | $- | ▲ +0 days |
| 2025 | 13 days | $2.51 Million | $188.42K/day | $- | $- | ▼ -28 days |
| 2024 | 41 days | $5.50 Million | $133.17K/day | $- | $- | ▲ +34 days |
| 2023 | 7 days | $885.00K | $118.62K/day | $- | $- | ▼ -98 days |
| 2022 | 105 days | $12.86 Million | $121.97K/day | $- | $- | ▲ +83 days |
| 2021 | 22 days | $1.14 Million | $51.43K/day | $- | $- | ▼ -50 days |
| 2020 | 73 days | $3.04 Million | $41.97K/day | $- | $- | ▼ -2769 days |
| 2019 | 2842 days | $2.96 Million | $1.04K/day | $- | $- | — |